Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychometric Evaluation of ARTSP in Allergic Rhinitis
NCT01287364Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Feb 2011
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by Sumitomo Pharma America. Started Feb 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01287364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287364.